Azelastine nasal spray is associated with a reduced risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

From L-R, Garcia, Wahl and Battaglia Approximately 15 million to 20 million Americans who have acquired COVID-19 experience ...

New research reveals promising drug targets to block coronaviruses at multiple stages of infection—even across different ...

New evidence suggests that SARS-CoV-2 infection can lead to the rapid development of achalasia, a rare esophageal motility disorder. The etiology of achalasia is unclear. Studies have suggested an ...

In a recent review published in the journal Cell Communication and Signaling, a team of researchers in Egypt and the United States explored the direct and indirect mechanisms of T lymphocyte-linked ...

Despite vaccines and treatments, SARS-CoV-2-the virus that causes COVID-19-continues to pose a global health threat, driven ...

In maintenance hemodialysis (MHD) patients infected with SARS-CoV-2, various thromboembolic complications have been reported, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Nearly 85% of people with long COVID had experienced ...

Since the start of the COVID-19 pandemic, there has been controversy surrounding the origins of SARS-CoV-2. New research from the University of California, San Diego (UCSD), School of Medicine ...

It is well-established that COVID-19 is a systemic disease. Besides the respiratory system, the virus can infect different ...